These studies suggest that GLP-1 and its receptor play a role in the pathophysiology of congenital hyperinsulinism and that targeting the GLP-1 receptor may be an effective treatment approach for this condition ( ATP hyperinsulinism and decreases glucose infusion rate requirements in infants with K ATP hyperinsulinism ( Role of GLP-1 in Hyperinsulinemic Hypoglycemia Secondary to Gastric Surgery Plasma glucose homeostasis, particularly in the post-prandial state is altered after gastric surgery, including gastrectomy, fundoplication, and bariatric procedures ( via increased GLP-1 release potentiating insulin secretion
Rowbottom, L., Stinson, J., McDonald, R., Emmenegger, U., Cheng, S., Lowe, J., Giotis, A., Cheon, P., Chow, R., Pasetka, M., et al
5c) and received the support of our MD studies in which compound 2-bound GLP-1R could stably bind to GLP-1 in the absence of G protein (Supplementary Fig
The titration schedule is very important because retatrutide is a powerful triple receptor agonist that can cause gastrointestinal side effects when taken at higher doses
The situation is more nuanced than headlines suggest Zepbound removal only affects the obesity indication, not sleep apnea or diabetes
